by Gary Pepper M.D. | Sep 5, 2016 | diabetes, general health & nutrition, Medical Economics, thyroid cancer
By Gary Pepper, M.D. A survey by metabolism.com reveals that a vast majority of the public believe doctors in the US are overly influenced in their decisions by the pharmaceutical industry. 500 visitors to the website participated in the survey. 419 (84%) answered... by Gary Pepper M.D. | Oct 6, 2014 | diabetes, Family Nutrition Diabetes, general health & nutrition, health insurance, Medical Economics
by Gary Pepper, M.D. “New is not always better.” This caution seems reasonable when considering the value of the recently approved medications for treatment of Type 2 (adult type) diabetes. Â These drugs include three new classes of medication referred to... by Dr. G. Pepper | Jan 1, 2012 | diet, diet and weight loss, fitness, general health & nutrition, health, nutrition, thyroid, weight gain, weight loss
My ebook Metabolism.com is now available; I think you will find it a great resource for many of the common problems members have asked me about over the past 15 years. Buy it now and use it for years to come. Don’t forget to check out the Weight Loss and Weight... by Dr. G. Pepper | Jul 6, 2011 | diabetes, diet, diet and weight loss, general health & nutrition, health, metabolism, Uncategorized
The lawsuits against Avandia are being prepared and opportunists are lining up for a payday. Unfortunately, everyone else will wind up a loser, and here’s why. Avandia, one of only two available medicines with unique properties to treat diabetes, was approved in... by Dr. G. Pepper | May 16, 2011 | diabetes, diet, general health & nutrition, health, metabolism, weight gain
(I don’t think so, and here’s why.) The FDA just announced its approval of linagliptin (Tradjenta), a new diabetes medication developed by Eli Lilly and Company and Boehringer Inglheim. Linagliptin is the third drug to be approved in the class of medications...